Yahoo
NasdaqCM - Nasdaq Real Time Price USD

Akebia Therapeutics, Inc. (AKBA)

0.7065 -0.0357 (-4.81%)
At close: October 30 at 4:00:01 PM EDT
0.6910 -0.0155 (-2.19%)
Pre-Market: 4:40:01 AM EST

Valuation Measures

Currency in USD Download
Current 6/30/2026 3/31/2026 12/31/2025 9/30/2025 6/30/2025
Market Cap
196.11M 305.81M 372.35M 427.24M 723.85M 955.99M
Enterprise Value
95.53M 194.19M 239.31M 313.37M 639.90M 896.77M
Trailing P/E
-- -- -- -- -- --
Forward P/E
28.75 -- 34.75 8.94 24.82 --
PEG Ratio (current)
-- -- -- -- -- --
Price/Sales
0.86 -- -- -- -- --
Price/Book
7.69 -- -- -- -- --
Enterprise Value/Revenue
0.44 0.84 1.01 1.39 3.14 4.85
Enterprise Value/EBITDA
66.94 53.61 11.01 14.76 58.14 136.14
6/30/2025 - 3/20/2014

Upgrade to begin using 40 years of earnings data and get so much more.

Build financial models with decades of earnings stats, ratios, and valuation data — all exportable — to power your trade ideas.

Upgrade

Financial Highlights

Fiscal Year

Fiscal Year Ends 12/31/2025
Most Recent Quarter (mrq) 6/30/2026

Profitability

Profit Margin -13.54%
Operating Margin (ttm) -5.46%

Management Effectiveness

Return on Assets (ttm) -1.05%
Return on Equity (ttm) -109.38%

Income Statement

Revenue (ttm) 219.06M
Revenue Per Share (ttm) 0.82
Quarterly Revenue Growth (yoy) -21.40%
Gross Profit (ttm) 178.4M
EBITDA -4.3M
Net Income Avi to Common (ttm) -29.67M
Diluted EPS (ttm) -0.1200
Quarterly Earnings Growth (yoy) --

Balance Sheet

Total Cash (mrq) 155.55M
Total Cash Per Share (mrq) 0.56
Total Debt (mrq) 199.19M
Total Debt/Equity (mrq) 796.18%
Current Ratio (mrq) 1.43
Book Value Per Share (mrq) 0.09

Cash Flow Statement

Operating Cash Flow (ttm) 41.55M
Levered Free Cash Flow (ttm) 33.64M

Trading Information

Stock Price History

Beta (5Y Monthly) 0.22
52 Week Change 3 -66.65%
S&P 500 52-Week Change 3 10.63%
52 Week High 3 2.2200
52 Week Low 3 0.5420
50-Day Moving Average 3 0.8462
200-Day Moving Average 3 1.1469

Share Statistics

Avg Vol (3 month) 3 7.84M
Avg Vol (10 day) 3 9.31M
Shares Outstanding 5 277.11M
Implied Shares Outstanding 6 277.11M
Float 8 272.25M
% Held by Insiders 1 1.98%
% Held by Institutions 1 40.64%
Shares Short (10/15/2026) 4 23.07M
Short Ratio (10/15/2026) 4 3.26
Short % of Float (10/15/2026) 4 8.45%
Short % of Shares Outstanding (10/15/2026) 4 8.33%
Shares Short (prior month 9/15/2026) 4 20.5M

Dividends & Splits

Forward Annual Dividend Rate 4 --
Forward Annual Dividend Yield 4 0.00%
Trailing Annual Dividend Rate 3 0.00
Trailing Annual Dividend Yield 3 0.00%
5 Year Average Dividend Yield 4 --
Payout Ratio 4 --
Dividend Date 3 --
Ex-Dividend Date 4 --
Last Split Factor 2 --
Last Split Date 3 --

Footnotes

  • 1 Data provided by Refinitiv.
  • 2 Data provided by EDGAR Online.
  • 3 Data derived from multiple sources or calculated by Yahoo Finance.
  • 4 Data provided by Morningstar, Inc.
  • 5 Shares outstanding is taken from the most recently filed quarterly or annual report and Market Cap is calculated using shares outstanding.
  • 6 Implied Shares Outstanding of common equity, assuming the conversion of all convertible subsidiary equity into common.
  • 7 EBITDA is calculated by S&P Global Market Intelligence using methodology that may differ from that used by a company in its reporting.
  • 8 A company's float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which may not be publicly traded.

Abbreviation Guide

  • mrq  =  Most Recent Quarter
  • ttm  =  Trailing Twelve Months
  • yoy  =  Year Over Year
  • lfy  =  Last Fiscal Year
  • fye  =  Fiscal Year Ending

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: